Somewhat Positive Media Coverage Somewhat Unlikely to Affect NxStage Medical (NXTM) Stock Price

News articles about NxStage Medical (NASDAQ:NXTM) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NxStage Medical earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the medical device company an impact score of 47.2174719027211 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of NxStage Medical stock opened at $24.53 on Friday. The stock has a market cap of $1,626.85, a price-to-earnings ratio of -350.43 and a beta of 0.02. NxStage Medical has a 1 year low of $20.45 and a 1 year high of $30.80.

Several equities analysts have commented on the stock. Zacks Investment Research cut shares of NxStage Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, February 13th. BidaskClub cut shares of NxStage Medical from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 15th. Finally, ValuEngine cut shares of NxStage Medical from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Three equities research analysts have rated the stock with a sell rating and eight have given a hold rating to the stock. The company currently has an average rating of “Hold” and an average price target of $30.25.

In other news, SVP Winifred L. Swan sold 3,500 shares of NxStage Medical stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $24.48, for a total transaction of $85,680.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 4.70% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect NxStage Medical (NXTM) Stock Price” was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3298726/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-nxstage-medical-nxtm-stock-price.html.

About NxStage Medical

NxStage Medical, Inc is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets.

Insider Buying and Selling by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Bank of New York Mellon Corp Takes Position in FS Bancorp
Bank of New York Mellon Corp Takes Position in FS Bancorp
Baxter Bros Inc. Sells 220 Shares of Amazon.com
Baxter Bros Inc. Sells 220 Shares of Amazon.com
Sprott Physical Gold  Stake Raised by Bank of New York Mellon Corp
Sprott Physical Gold Stake Raised by Bank of New York Mellon Corp
Peoples Bancorp of North Carolina, Inc.  Holdings Lifted by Bank of New York Mellon Corp
Peoples Bancorp of North Carolina, Inc. Holdings Lifted by Bank of New York Mellon Corp
Vanguard Telecommunication Services ETF  Shares Bought by Bank of New York Mellon Corp
Vanguard Telecommunication Services ETF Shares Bought by Bank of New York Mellon Corp
Aries Wealth Management Takes Position in Facebook, Inc.
Aries Wealth Management Takes Position in Facebook, Inc.


© 2006-2018 Ticker Report. Google+.